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Abstract Studies of transgenic mice have shown that transcrip- 
tional control of the gastrin gene exhibits significant species dif- 
ferences. Transfection of the human gastrin promoter in murine 
cells have depicted proximal Spl, E-box and CACC elements as 
the major determinants of transcription. We have examined cis- 
regulatory elements of the human promoter in a human gastrin 
expressing cell line and find that a distal -135 to -142 Spl 
element is necessary for maximal activity. Alignment of the 
mouse and human promoters hows that the proximal human Spl 
and CACC elements are not conserved, whereas the E-box ele- 
ment is retained. The distal Spl element is present in mouse but 
exhibits a C to T transition in the core that is likely to reduce 
binding affinity of Spl. We conclude that gastrin gene transcrip- 
tion is regulated by distinct elements in man and rodents. 
K<v word~. Transcription factor: Spl:  Gastr in promoter: 
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I. Introduction 
The peptide hormone gastrin is an important  regulator of 
gastric acid secretion and growth of the gastrointestinal mucosa 
[1]. In fetal litE gastrin is expressed in the pancreas [2] and the 
colon [3], whereas antral  G-cells are the main site of synthesis 
in adults [l]. Hence, gastrin expression is tissue specific and 
developmentally regulated, 
Studies oftransgenic mice have indicated that transcriptional 
control of the gastrin gene exhibits significant species differ- 
ences and may be controlled by distinct promoter  elements in 
man and rodents. In these experiments the human gastrin pro- 
rooter did not direct transcription to antral  G-cells, but was 
only active in the liver [4] and the pancreatic islets [4,5]. In 
contrast, the rat gastrin promoter  directed expression to the G 
cells, while expression in fetal pancreas was absent [5]. Previous 
studies of the human gastrin promoter in murine cell lines have 
revealed both positive and negative regulatory cis-elements in 
the proximal upstream regulatory domain [6-9]. In two rat 
insul inoma cell lines, maximal activity of the promoter  was 
mediated by the concerted action of an Spl,  E-box and a CACC 
element within 111-bp upstream of the transcription initiation 
site (Fig. I ). 
in this study, we have depicted cis-regulatory elements in the 
human gastrin promoter by deletion analysis in human gastric 
adenocarc inoma AGS cells. We report the presence of a novel 
distal Spl element necessary for maximal activity of the proxi- 
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mal part of the gastrin promoter. Moreover, we have deter- 
mined the sequence of the mouse gastrin gene promoter to 
compare c/s-regulatory elements between rodents and man. 
2. Materials and methods 
2.1. Materials 
The gastric adenocarcinoma cells, AGS, were obtained from Ameri- 
can Type Culture Collection (Rockville, Maryland, USAI. pCAT-basic 
and recombinant human Spl transcription factor were from Promega 
(USA). Rabbit polyclonal Spl antibody was from Santa Cruz Biotech- 
nology tSanta Cruz, California, USA). Control rabbit polyclonal anti- 
serum, c-fos(Ab-2), was from Oncogene Science. The GASCATI300 
plasmid, which contains equence -1300 to +57 relative to the cap-site 
[10], was a kind gilt from Dr. Jens Vuust, Copenhagen, Denmark. 
2.2. Isolation ~[' the mouse gastrin gene promoter 
The mouse gastrin gene was isolated from a 129 SVJ mouse genomic 
library (Stratagene). The library was screened with a mouse gastrin gene 
specific probe, that had been amplified by PCR using mouse genomic 
DNA and primers pecific for rat gastrin. These primers were comple- 
mentary to positions 4(>59 and 347 356 of the rat gastrin cDNA [11]. 
The gastrin promoter sequence is reported in this paper, whereas the 
gene sequence will be reported elsewhere. 
2.3. Plasmid ~ onstru~tions 
Deletion constructs of the 5' upstream regulatory region of the 
human gastrin gene were generated by PCR using GASCATI300 as 
template [10]. The 3' PCR primer encompassed the Pstl-site located at 
position 3241 of the human gastrin gene in exon 1 [12], whereas the 5' 
primers were specific for upstream promoter sequences and contained 
a HindlII site to facilitate cloning in the p0CAT vector. The p0CAT 
vector is a p('AT-basic derivative, where the original BamHI site has 
been removed and a HindIIl site added to the multiple ckming site. The 
GASCAT142 with a mutated Spl-site was constructed with the mutant 
primer: 5'-TAT AAA AGC TTA AGT TCG GGG CAG GGT GAT 
GGG CTG-3'. 
2.4. Cell culture and transJection.s 
AGS cells were cultured at 5% CO, and 37°C in Ham's F-12 supple- 
mented with 10% fetal calf serum, 1% glutamine and 1% penicillin- 
streptomycin. One day prior to transfection, cells ~ere split and 
1.5 x 10 ~' cells seeded in 100-mm Petri dishes. Cells were transfected 
with 20 ,ug of DNA from the deletion constructs using the modified 
calcium phosphate method of Chen and Okayama [13] as previously 
described [14]. To normalize CAT activity cells were co-transfected with 
5/ag pCH110, a vector which expresses the ,8-galactosidase g ne [15]. 
Two days after transfection, cells were harvested and stored at -80°C. 
The chloramphenicot acetyl-transferase and fl-galactosidase assays 
were perlk~rmed essentially as described [15,16]. 
2.5. Preparation of  nuclear extracts 
Nuclear extracts were prepared essentially as described [14,17]. Ap- 
proximately 1.5 x 10 9 cells were harvested, washed and resuspended in 
4 m110 mM Hepes, pH 7.8, 15 mM KC1, 2 mM MgCt> 0.1 mM EDTA, 
1 mM DTT, 2.8 ,ug/ml aprotinin (buffer A). After 15 min at 0°C the 
cells were homogenized with a Dounce homogenizer and centrifuged 
at 4000 xg  t\,r I0 min at 4°C. The pellet was resuspended in 3 ml of 
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buffer A per 109 cells, NaC1 added to a final concentration f450 mM 
and the extract gently shaken for 30 min at 0°C. After centrifugation 
at 16,000 x g for 60 rain at 4°C the supernatant was recovered and 
(NH4)SO2 added to a final concentration f 300 mg/ml. The extract was 
incubated for 60 min at 0°C with gentle stirring. After centrifugation 
at 16,000 x g for 15 min at 4°C, the pellet was resuspended in 0.4 ml 
orS0 mM Hepes, pH 7.8, 50 mM KCI, 0.1 mM EDTA, 1 mM DTT, 
1 mM PMSF with 10% glycerol, per 10 9 cells and dialyzed against he 
same buffer. Finally, the extract was centrifuged at 18,000 x g for 15 
min and the supernatant aliquoted and stored at -80°C. The protein 
content of the extract was determined using the Bradford method [18]. 
2.6. Gel mobility shift assay 
Approximately 10 fmol of a double-stranded oligonucleotide gastrin 
Spl (gSpl) (5'-AAT GAA AGG GCG GGG CAG GGT GAT GGG 
C-3'), was labeled with [F-32p]ATP and incubated with 5/zg of nuclear 
extract in the presence or absence of unlabelled competitor in 25 mM 
Hepes, pH 7.9, 150 mM KC1, 10% glycerol, 5 mM DTT at 0°C for 30 
min. A double-stranded Spl consensus binding site oligonucleotide, 
(Spl) (5'-GAT CCC TTG GTG GGG GCG GGG CCT AAG CTG 
CGC AT-3'), was used as a competitor. Loading buffer with 5% glyc- 
erol was added to the samples which were applied to a 4% non-denatur- 
ing polyacrylamide gel. 
In the supershift assay, the mixtures of labeled oligonucleotide and 
nuclear extracts were incubated with 0.1-1/IM antibody for 2 h at room 
temperature. These samples underwent electrophoresis ona 1% agarose 
gel in 0.5 × TBE which was fixed in 10% trichloroacetic a id and dried 
in a slab dryer (Bio-Rad) prior to autoradiography. 
3. Results and discussion 
3.1. Identification of  5' upstream cis-regulatory elements 
Cis-regulatory elements in the human promoter  were exam- 
ined by transient ransfection of AGS cells with a series of 
promoter  deletions fused to the cat reporter gene (Fig. 2). The 
gastrin promoter  is highly active in AGS cells and exhibits 
similar activity as the Rous sarcoma virus promoter  (data not 
shown). The proximal 142 bp of the promoter  exhibit about 
50% of the activity of the 1300-bp region, whereas the proximal 
82 bp only provides 25% of maximal activity. Positive elements 
are located within the proximal 82 bp and in the -84  to -115 
and -135 to -142 regions. Putative negative lements are local- 
EXONI~ EXON2 EXON3 
/ 
-149  ~ ~ ~ ~ ~ ~ ~ ~ 
AT- r i ch  Spl ~ ~ ~ 
~AAG~G~]GGG CAGG GTGATGGGCTGTACCTGTGC 
-142 -135 -115 
0- CACC- box E-box 
-1 
-84 -82 
-68  Sp l  
GC~GGTGGGGGGACAG TTGGGAGGGACCTTGAGGGC 
-28  -1~ 
TT~'N~GGCAGGCCTGGAGCATCAAGCAGAGCAGAGACC 
Fig. 1. Structure of the human gastrin gene and sequence of the prox- 
imal promoter region. The gene consists of three exons of which exon 
one comprises the 5' untranslated mRNA. The blow out shows the 
sequence of the region -149 to +12 relatively to the cap-site, marked 
with an asterisk [10]. Previously reported cis-elements are boxed, and 
deletion points of the promoter constructs are marked with arrows. 
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Fig. 2. Transient expression of gastrin gene promoter-cat fusion con- 
structs in human AGS cells. Data are expressed relatively to the activity 
of the -1300 promoter region and are mean + S.D. of three independ- 
ent experiments. 
ized in the -82  to -84  and -115 to -135 regions, and upstream 
o f -142  bp. The proximal 82-bp region includes an Spl site and 
an E-box motif(Fig. 1) which is the binding site of transcription 
factors of the helix-loop-helix family, the -84  to -115 region 
contains the recently described CACC element hat binds a 
70-kDa trans-acting factor [9]. Maximal activity of the proximal 
promoter equires the inclusion of bp -135 to -142. Since this 
stretch contains a putative Spl binding site, we examined the 
binding of this factor. 
Recombinant  Spl bound to the promoter element and comi- 
grate with the major trans-acting factor in nuclear extracts (Fig. 
3). Binding was competed with 100-fold excess of unlabelled 
1 2 3 4 5 6 7 8 9 10 
*-B 
Fig. 3. Gel mobility shift assay of the -135 to -142 Spl element, gSpl 
was used as labelled probe (lane 1) and added the following: lane 2: 
recombinant Spl (rSpl); lane 3: rSpl and Spl antibody; lane 4: rSpl 
and control antiserum; lane 5: AGS nuclear extract; lane 6: nuclear 
extract and 100-fold excess unlabelled Spl probe; lane 7 9: nuclear 
extract and increasing amounts of Spl antibody; lane 10: nuclear ex- 
tract and control antiserum. The arrow marked B indicates the bound 
probe, whereas A marks the supershifted band. 
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Fig. 4. Mutational effect of the -135 to -142 Spl binding site. CAT 
activities of AGS cells transfected with human gastrin promoter dele- 
tions and the mutant 142(ASpl), inwhich the GGCG core of the Spl 
site has been altered to TTCG. 
Spl consensus probe, and Spl specific antibodies supershifted 
the trans-acting factor in nuclear extract. In the samples with 
nuclear extract wo additional bands are apparent in the gel 
mobility shift assay. Binding was competed with 100-fold excess 
of Spl probe indicating that the factors represent isoforms of 
Spl, e.g. the phosphorylated form, and/or interactions with 
other factors. To examine the functional significance of the Spl 
element the cells were transfected with constructs including a
mutation in the Spl binding site. A double mutation in the core 
consensus sequence r duces promoter activity to the level of the 
-135 construct (Fig. 4), indicating that Spl binds a distal site 
in the gastrin promoter and is necessary for maximal activity 
of this region. 
Spl is a general transcription factor involved in the control 
of a variety of genes. It has been suggested, that Spl is normally 
present in limiting amounts which may increase in response to 
physiological stimuli [19]. Moreover, Spl levels varies up to 
100-fold with the highest expression in cells undergoing late 
stages of differentiation, which includes antral gastrin express- 
ing cells [19]. Therefore Spl is likely to be involved in both basal 
and regulated of gastrin gene transcription. 
3.2. ComparLs'on o[human and mouse cis-regulatory elements 
To examine the conservation of the respective cis-regulatory 
elements, we cloned and sequenced the proximal part of the 
mouse gastrin gene promoter (Fig. 5). When comparing the 
proximal 300 bp of the mouse and human gastrin promoters 
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they were found to possess an overall homology of 72% with 
the region immediately 5'of the cap-site, including the TATA- 
box, being highly conserved. Similarly, the E-box motif of the 
human promoter (Fig. 1, 5'-CATATG-3'), which is the binding 
site of transcription factors of helix-loop-helix family and en- 
hances transcription i  murine cells [6], is conserved in the 
mouse. However, only the consensus element of the E-box is 
conserved (5'-CANNTG-3'). This suggests an important role 
of the E-box in regulation of gastrm gene expression. 
In this study, we have demonstrated the importance of a 
distal Spl binding site that has also recently been reported to 
be active in nmrine cells [20]. This element is also conserved in 
the mouse promoter. However, the 5'-GGCG-3' core of the Sp 1 
binding site has been altered to 5'-GGTG-3'. Though this con- 
stitutes a putative Spl binding, the substitution reduces binding 
affinity of Spl 6-fold compared to that of the ideal Spl consen- 
sus [21]. 
Apart from these e/s-regulatory elements, there are substan- 
tial differences between regulatory elements in the human pro- 
moter and putative lements in the mouse promoter. For in- 
stance, enhancement of gastrin transcription by EGF has been 
proposed to be mediated by a Spl binding site at positions -68 
to -53 of the human promoter [22], however this element isnot 
present in the same region of the mouse promoter. Similarly, 
the CACC-box proposed to be the binding site of a 70-kDa 
activator is not conserved except as a part of the mouse E-box. 
In the mouse the presence of an element equivalent to an AT- 
rich region m -149 to -143 bp ot' the human promoter is 
uncertain. This element was recently proposed to be the binding 
site of a regulator of expression i  insulinoma cells [2()]. In thc 
HUMAN G-AT-A-AGTGCC . . . .  GAGGCCTCTGA- CC . . . . .  CCCA-GG ATATG 
I II I I I I  II II I II II I I t i l l  II I I I  
MOUSE GGATGATAGT CCAATAGAAGACTAGGAAGCCGATGGCCCAAGGCATACA 
HUMAN GTGGGA--AGCATTGCTCCTG---ACCCAGGGAG CTTGGTTCCTGCCCC 
I I I I l l  I I I I I  BI I I I  i l l l l  II I I  If l i  
MOUSE GTACAATGAGC--TGCTC-TGGAGACC-AGGGAATCT--GT--CT- -CC 
HUMAN 
MOUSE 
TCAGGTACAGCTGGAGAGCTGCCGCCACCCCGCTCCAGCCCCTCACCATG 
I I I I I I  II II I I I  I I I I I I I I I I I  I I  I 
T- - -GT  . . . .  CTGT . . . .  CT . . . .  CCTCCCTGTTTCAGCCCCTC-CC-T 
HUMAN 
MOUSE 
AAGGTCAACTCCCC-TATCCT---TCCCCCACATC-CTGGATGACTGACT 
I l t l l l  I I I  I I  I I II I I I I I l l  I 
. . . .  7 TCCCCATATTCTGAAT- - AAATAACTA-AT- - -TGATT 
HUMAN GACA CTAAATGAAAGGGCGGGGCAGGGTGATGGGCTGTACCTG- TGCC 
l l l l  iI i l l  I1~1!11111t I l l l  II II ~IIL I I/ 
MOUSE GACAGCTCTGTGACAG~T~GGGGCAGAGTGACAGGTTGAACCTACAT T C C 
HUMAN CCAC-CCCATTCCTCTCGC . . . . . . . .  CTGGACTC~GCAGGGTA 
I IL l l tL l l l l  II l i l l  I I~ i l  ll~ 
MOUSE --AGGCCCATTTCTCTTGCTGTGGGGAGTCTGGCCTG-ACC[.~GAAGG--A 
HUMAN GGGGCGGGGTGGGGGGACAGTTGGGAGGGACCTTGAGGGCTTTAT~AGGC 
taB t t t i t t l t t  t i l l  t ! t t i t l t : i i i~ i I~![ i l i tL  
MOUSE GGG . . . . .  T . . . . .  TTGGGAGGAACCTCGAGGGCTTTA~AAGGC 
HUMAN AGGCCTGGAGCATCA- AGCAGAGCAGAG 
II l l l l l l l l L  l l l l l l l l111J  
MOUSE AGACCTGGAGCAGCGCA- CAGAGCAGAG 
Fig. 5. Comparison of the human and mouse gastrin promoters. The 
sequence from -327 to +9 of the human promoter and from -301 1o 
+9 of the mouse promoter were aligned. The conserved cis-regulatory 
elements are shaded in grey. The cap-site is marked by an asterisk. 
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mouse, an AT-rich stretch is located nearby in the mouse pro- 
moter, but it is not clear if the factor described in murine cell 
extracts will bind to this element. 
In line with the previous observations in transgenic mice 
[4,5], our data suggest hat there are important differences in 
the transcriptional regulation of gastrin expression in man and 
rodents. Hence, these differences hould be taken into account 
in the analysis of transcriptional ctivation of the gastrin gene. 
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